European Pharmaceutical Pricing and Reimbursement Conference 2012

SMi is proud to announce the lastest conference in it's Pricing & Reimbursement series. Building on the success of our previous events, this exciting conference will provide attendees with a complete view of the pricing and market access fields. Focusing on the development of novel pricing amd market access strategies, this informative conference will bring together key opinion leaders in the field to provide attendees with an in depth look into current advances in pharmaceutical pricing and reimbursement.

This long established event, now in its 18th year, will bring together a unique group of people to discuss the key developments in the field. With speakers from all over Europe and further afield this event will be the perfect platform to share knowledge, debate the latest pricing systems accross the EU and evaluate price referencing strategies.

• Learn about the benefits and obstacles when collaborating with HTAs

• Discuss market access strategies for Orphan Drugs

• Consider developments in the pricing of biosimilars and biobetters

• Understand the consqeuences of Germany's AMNOG

• Debate the importance and success rates of risk sharing agreements

• Evaluate current strategies for pricing and reimbursement in emerging markets

• Develop ideas and network with key industry professionals

Featured Speakers

Pierrick Rollet,Thilo Schaufler,Timothy Lenehan